Purpose/Scope: These Funds Will Support the Design and Eventual Construction of a 20-MEGAWATT Research…
FY2023 · complete year · data as of 2026-07-03
A single federal award, with both ends of the trail linked.
Award 60NANB23D160 is a grant from the Department of Commerce to University of Missouri System, $19.8M obligated, FY2023 to FY2027, for Purpose/Scope: These Funds Will Support the Design and Eventual Construction of a 20-MEGAWATT…. The work is performed in Missouri. Source
Description
Purpose/Scope: These Funds Will Support the Design and Eventual Construction of a 20-MEGAWATT Research Reactor Specifically Designed and Built to Produce Critical Short-Lived Medical Radioisotopes for Use in Diagnostic and Therapeutic Radiopharmaceuticals. This Construction Will Expand Capability That Will Compliment and Strengthen the Life-Saving Medical Research Being Conducted at the Mu Nextgen Precision Health Facility by Adding World-Class Capabilities in Medical Radioisotopes, Nuclear Medicine, and Molecular Imaging as Well as Creating a National Cluster for Innovation in Drug Discovery. Murr Nextgen Will Be a 20 MW Research Reactor Specifically Designed and Constructed Over the Next Decade to Produce Critical Short-Lived Medical Radioisotopes for Use in Diagnostic and Therapeutic Radiopharmaceuticals.activities to Be Performed: An Early Investment Would Allow for Completion of the Reactor Design with a Mandate to Engage Research and Industry Stakeholders. The Study Will Develop the Reactor Design and Outline Functional Specifications in Sufficient Detail to Permit Soliciting Construction Bid Proposals for a State-Of-The Art, Next Generation Medical Isotope Production and Research Reactor to Be Built at Discovery Ridge. Some Funds Would Also Be Used to Help Establish a Core Project Management Team of World-Class Professionals, Dedicated to the Murr Nextgen Project Who Will Begin the Nuclear Regulatory Approval Process and Develop the Necessary Stakeholder Engagement Platform.expected Outcomes: The New Reactor Will Take on the Existing Supply Responsibility of the Aging University of Missouri Research Reactor, Which Is Currently the Sole U.S. Supplier of Five Short-Lived Medical Radioisotopes Critical to Patient Diagnosis and Treatment of Heart Disease and Cancer.intended Beneficiaries:murr Nextgen's Novel Design, Higher Power and Isotope Production Capacity Will Ensure National Security of Supply for Existing Health Care Products and Serve as a Reliable Platform for Innovation of New Cancer Drugs and Life Sciences Innovations.subrecipient Activities: None